Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,77%
1.097,81
-8,55
-0,77%
—1.106,361.105,681.109,291.096,52——
SIXC
Communications
SIXC
Communications
SIXC
+0,29%
612,03
+1,74
+0,29%
—610,29610,29616,60610,29——
SIXE
Energy
SIXE
Energy
SIXE
+0,76%
1.220,43
+9,21
+0,76%
—1.211,221.211,011.222,361.208,50——
SIXI
Industrials
SIXI
Industrials
SIXI
+0,50%
1.759,52
+8,81
+0,50%
—1.750,711.753,101.762,131.743,30——
SIXM
Financials
SIXM
Financials
SIXM
+0,54%
631,54
+3,37
+0,54%
—628,17629,38634,09629,38——
SIXR
Staples
SIXR
Staples
SIXR
+0,30%
857,16
+2,59
+0,30%
—854,57855,71860,09855,45——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,67%
215,41
-1,46
-0,67%
—216,87216,87217,79215,29——
SIXT
Technology
SIXT
Technology
SIXT
+1,47%
3.614,15
+52,21
+1,47%
—3.561,943.571,443.628,583.562,15——
SIXU
Utilities
SIXU
Utilities
SIXU
+0,55%
908,30
+4,99
+0,55%
—903,31903,26908,38901,18——
SIXV
Health care
SIXV
Health care
SIXV
-0,08%
1.480,40
-1,14
-0,08%
—1.481,541.482,481.488,461.474,18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,07%
2.398,37
-1,58
-0,07%
—2.399,952.404,452.418,812.396,04——
BNTX:NASDAQ
BioNTech SE - ADR
US$91,99
-0,26%
(-0,24) 1D
US$91,99
0,00% (0,00)
After hours
Closed: 14 ພ.ພ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BNTX...
Open
US$92,00
High
US$92,86
Low
US$90,88
Mkt. cap
໒໓,໒໖ ຕື້
Avg. vol.
໘໙໑,໒໒ ພັນ
Volume
໖໔໖,໕໐ ພັນ
52-wk high
US$123,98
52-wk low
US$79,52
EPS
US$-5,94
Beta
໑,໓໔
Shares outstanding
໒໕໒,໘໘ ລ້ານ
No. of employees
໘ ພັນ
News stories
From sources across the web
Stock Titan
Stock Titan
·
4 ຊົ່ວໂມງກ່ອນ
ATHOS group holds 101.7M BioNTech shares (BNTX) — 40.2% stake
AD HOC NEWS
AD HOC NEWS
·
6 ຊົ່ວໂມງກ່ອນ
BioNTech SE stock (US09075V1026): Insider equity grants filed for top executives
Profile
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes. In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic. Wikipedia
About BioNTech SE - ADR
CEOUğur Şahin
Employees7,81 ພັນ
Founded2008
Headquarters-
SectorBiotechnology
Websitebiontech.de
Last report
5 ພ.ພ. 2026
Fiscal Period
Q1 2026
EPS / Est. (EUR)
€-1,95 / €-1,92
-1,62%miss
Revenue / Est. (EUR)
໑໑໘,໑໐ ລ້ານ / ໑໕໕,໓໘ ລ້ານ
-23,99%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
ມິ.ຖ. 2025
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
Revenue
260,80 ລ້ານ
1,52 ຕື້
907,40 ລ້ານ
118,10 ລ້ານ
Cost of goods sold
76,40 ລ້ານ
148,30 ລ້ານ
302,80 ລ້ານ
71,40 ລ້ານ
Cost of revenue
76,40 ລ້ານ
148,30 ລ້ານ
302,80 ລ້ານ
71,40 ລ້ານ
Research and development expenses
509,10 ລ້ານ
564,80 ລ້ານ
505,40 ລ້ານ
557,00 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
137,40 ລ້ານ
148,50 ລ້ານ
217,90 ລ້ານ
150,80 ລ້ານ
Operating expense
621,10 ລ້ານ
1,40 ຕື້
907,20 ລ້ານ
727,70 ລ້ານ
Total operating expenses
697,50 ລ້ານ
1,55 ຕື້
1,21 ຕື້
799,10 ລ້ານ
Operating income
-436,70 ລ້ານ
-33,00 ລ້ານ
-302,60 ລ້ານ
-681,00 ລ້ານ
Other non operating income
105,40 ລ້ານ
96,80 ລ້ານ
-173,80 ລ້ານ
42,10 ລ້ານ
EBT including unusual items
-402,70 ລ້ານ
24,70 ລ້ານ
-227,40 ລ້ານ
-568,10 ລ້ານ
EBT excluding unusual items
-379,30 ລ້ານ
40,70 ລ້ານ
-206,50 ລ້ານ
-567,80 ລ້ານ
Income tax expense
-16,10 ລ້ານ
53,40 ລ້ານ
77,60 ລ້ານ
-36,20 ລ້ານ
Effective tax rate
4,00%
216,19%
-34,12%
6,37%
Other operating expenses
-25,40 ລ້ານ
690,30 ລ້ານ
183,90 ລ້ານ
19,90 ລ້ານ
Net income
-386,60 ລ້ານ
-28,70 ລ້ານ
-305,00 ລ້ານ
-531,90 ລ້ານ
Net profit margin
-148,24%
-1,89%
-33,61%
-450,38%
Earnings per share
-1,60
-0,12
-0,33
-1,95
Interest and investment income
-
-
265,50 ລ້ານ
61,70 ລ້ານ
Interest expense
-6,60 ລ້ານ
-2,60 ລ້ານ
-
-4,00 ລ້ານ
Net interest expenses
-6,60 ລ້ານ
-2,60 ລ້ານ
265,50 ລ້ານ
57,70 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
-385,70 ລ້ານ
91,20 ລ້ານ
-266,95 ລ້ານ
-559,70 ລ້ານ
Gain or loss from assets sale
-300,00 ພັນ
-1,30 ລ້ານ
-800,00 ພັນ
-100,00 ພັນ
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer